嘉和生物(06998.HK)溢价75.7%并购亿腾医药 今早复牌

阿斯达克财经
Oct 07, 2024

嘉和生物(06998.HK) 公布,将以合并方式收购标的公司亿腾医药集团。据此,公司的全资附属GenEdd将被合并并入亿腾医药,而亿腾医药将作为存续实体并成为公司的全资附属,收购代价将以配售合共18.21亿股股份支付,相当于扩大后股本约77.79%,每股作价2.899元,较停牌前收市价1.65元溢价约75.71%。公司于9月13日与亿腾医药订立CDK4/6i外包管理协议,据此,公委托亿腾医药于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10